- Home
- AIRT vs HRTX Comparison
AIRT vs HRTX Comparison
Compare AIRT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRT | HRTX |
|---|---|---|
| Founded | 1980 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.8M | 90.1M |
| IPO Year | 2018 | 2007 |
Fundamental Metrics
Financial Performance| Metric | AIRT | HRTX |
|---|---|---|
| Price | $29.37 | $0.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 16.7K | ★ 2.8M |
| Earning Date | 02-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1393.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $286,834,000.00 | $154,904,000.00 |
| Revenue This Year | N/A | $15.28 |
| Revenue Next Year | N/A | $20.29 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.98 | 7.36 |
| 52 Week Low | $18.35 | $0.30 |
| 52 Week High | $35.00 | $1.58 |
Technical Indicators
Market Signals| Indicator | AIRT | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 27.60 |
| Support Level | $20.19 | N/A |
| Resistance Level | $30.36 | $0.46 |
| Average True Range (ATR) | 2.05 | 0.04 |
| MACD | -0.40 | -0.01 |
| Stochastic Oscillator | 31.55 | 2.06 |
Price Performance
Historical ComparisonAbout AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include overnight air cargo, ground support equipment, commercial aircraft, engines and parts, digital solutions, and regional airline. The company generates maximum revenue from the overnight air cargo segment.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.